Sopharma AD Income Statement

Financials in millions BGN. Fiscal year is January - December.

Millions BGN. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Operating Revenue	2,490	2,121	1,875	1,663	1,603	1,439
Other Revenue	20.24	18.57	13.53	8.5	8.04	7.31
Revenue	2,511	2,139	1,889	1,672	1,611	1,446
Revenue Growth (YoY)	22.13%	13.27%	13.00%	3.73%	11.43%	12.27%
Cost of Revenue	1,935	1,675	1,470	1,306	1,264	1,131
Gross Profit	575.92	464.42	418.52	365.37	346.96	315.22
Selling, General & Admin	364.23	306.58	251.19	215.55	221.99	213.25
Other Operating Expenses	20.12	20	18	11.76	7.3	11.84
Operating Expenses	455.32	388.14	325.22	279.51	285.48	271.87
Operating Income	120.6	76.28	93.31	85.86	61.48	43.35
Interest Expense	-19.4	-12.87	-10.98	-6.02	-10.79	-12.41
Interest & Investment Income	3.45	2.94	3.42	3.19	4.87	5.23
Earnings From Equity Investments	42.99	25.72	24.47	22.64	12.09	5.98
Currency Exchange Gain (Loss)	-7.27	-5.76	-1.39	-0.13	2.29	-7.41
Other Non Operating Income (Expenses)	3.96	2.41	-2.55	-3.19	-0.94	-0.76
EBT Excluding Unusual Items	144.34	88.72	106.28	102.35	69	33.98
Impairment of Goodwill	-	-	-	-9.6	-	-3.5
Gain (Loss) on Sale of Investments	-0.02	0.1	0.95	-1.59	0.15	0.09
Gain (Loss) on Sale of Assets	1	1.33	4.53	1.95	38.01	0.41
Asset Writedown	-0.47	-0.42	-1.44	-8.46	-10.34	-2.32
Legal Settlements	-	-	-	-	-	0.17
Other Unusual Items	3.88	1.73	0.87	0.43	0.75	2.61
Pretax Income	148.72	91.46	111.2	85.08	97.57	31.44
Income Tax Expense	17.27	9.07	11.32	8.74	5.87	6.16
Earnings From Continuing Operations	131.44	82.4	99.87	76.33	91.7	25.28
Minority Interest in Earnings	-7.26	-4.55	-3.9	-5.21	-2.21	4.53
Net Income	124.18	77.85	95.98	71.12	89.5	29.81
Net Income to Common	124.18	77.85	95.98	71.12	89.5	29.81
Net Income Growth	50.20%	-18.89%	34.95%	-20.53%	200.27%	-65.74%
Shares Outstanding (Basic)	279	493	392	364	376	377
Shares Outstanding (Diluted)	279	494	415	375	376	377
Shares Change (YoY)	-46.99%	19.22%	10.64%	-0.36%	-0.31%	-0.11%
EPS (Basic)	0.44	0.16	0.24	0.20	0.24	0.08
EPS (Diluted)	0.44	0.16	0.23	0.19	0.24	0.08
EPS Growth	183.86%	-31.87%	21.05%	-19.73%	199.61%	-65.70%
Free Cash Flow	-23.97	43.25	20.64	90.74	-96.31	-202.96
Free Cash Flow Per Share	-0.09	0.09	0.05	0.24	-0.26	-0.54
Dividend Per Share	0.115	0.052	0.330	0.200	-	-
Dividend Growth	108.56%	-84.33%	65.00%	-	-	-
Gross Margin	22.94%	21.71%	22.16%	21.86%	21.53%	21.80%
Operating Margin	4.80%	3.56%	4.94%	5.14%	3.82%	3.00%
Profit Margin	4.95%	3.64%	5.08%	4.25%	5.55%	2.06%
Free Cash Flow Margin	-0.95%	2.02%	1.09%	5.43%	-5.98%	-14.04%
EBITDA	174.36	112.85	127.86	118.97	93.85	74.19
EBITDA Margin	6.94%	5.27%	6.77%	7.12%	5.82%	5.13%
D&A For EBITDA	53.76	36.57	34.56	33.11	32.37	30.84
EBIT	120.6	76.28	93.31	85.86	61.48	43.35
EBIT Margin	4.80%	3.56%	4.94%	5.14%	3.82%	3.00%
Effective Tax Rate	11.62%	9.91%	10.18%	10.28%	6.02%	19.60%
Advertising Expenses	-	1.98	2.27	22.06	27.41	28.5

Source: S&P Global Market Intelligence. Standard template. Financial Sources.